Next-generation gene-editing tool offers enhanced capabilities for cancer and medical research
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...
Gene therapy and bone marrow transplant alleviate ultra-rare genetic disease symptoms
In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...
PMLiVE2d
The silent treatment – researching gene silencing for Alzheimer’s, Parkinson’s and motor neurone disease
In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...
EuropaWire3d
Roche Reports Sustained Two-Year Improvements with Elevidys Gene Therapy for Duchenne Muscular Dystrophy
Roche has reported positive results from the second year of the EMBARK Phase III trial of Elevidys (delandistrogene moxeparvovec), the first approv ...
H.C. Wainwright maintains $30 target on Voyager Therapeutics stock
The confidence in Voyager Therapeutics (NASDAQ:VYGR)' stock is further supported by the company's strategic collaborations, ...
Hosted on MSN6d
5 US Longevity and Anti-aging Stocks to Watch in 2025
As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in ...